I agree with Weezuhl, let's keep this a polite forum. No need to insult other posters.
As far as why Generex didn't get any of their IP to amount to anything, IMO is due to the derivative/warrant overhang. They could not issue or raise new capital to continue with research. Now those issues are behind them. Let's hope that Joe and company can make the best of a "fresher" start, albeit not a new start.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.